MedTrace Logo

Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients

NCT01501448 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2016-03-22

No results posted yet for this study

Summary

The recent controversy regarding the use of pill for cycle planning in GnRH antagonists IVF cycle has driven the search for new ways to plan IVF cycles in order to avoid weekends or to equally distribute the workload. Recently, mid-late luteal phase oral estrogens seem to be as good as the pill. The investigators will compare OCP vs oral estrogens to plan the initiation of IVF cycles.

Conditions

Interventions

DRUG

Levonorgestrel and ethinylestradiol

30 microgram of ethinylestradiol plus levonorgestrel daily for 12 to 16 days

DRUG

Estradiol valerate

4mg estradiol valerate from cycle day 20 till the day before the initiation of the cycle

Sponsors & Collaborators

  • IVI Madrid

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
38 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-05-31
Completion
2013-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501448 on ClinicalTrials.gov